Read on Twitter
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals
Papier (preprint) sur la vaccination en Israël et les variants. Apparition plus marquée d& #39;infection postvac avec GB et SudAf que le WT. https://www.medrxiv.org/content/10.1101/2021.04.06.21254882v1">https://www.medrxiv.org/content/1...
Papier (preprint) sur la vaccination en Israël et les variants. Apparition plus marquée d& #39;infection postvac avec GB et SudAf que le WT. https://www.medrxiv.org/content/10.1101/2021.04.06.21254882v1">https://www.medrxiv.org/content/1...
Rassurant néanmoins
"These results overall suggest that vaccine breakthrough infection is more frequent with both VOCs, yet a combination of mass-vaccination with two doses coupled with non-pharmaceutical interventions control and contain their spread."
"These results overall suggest that vaccine breakthrough infection is more frequent with both VOCs, yet a combination of mass-vaccination with two doses coupled with non-pharmaceutical interventions control and contain their spread."
@EricBillyFR @Le___Doc @FZores @CovaFlorian @mimiryudo @Scintigraphiste @DavidHajage @AnthonyGuihur @nathanpsmad @T_Fiolet @MS_Yahya_ @Nibor_Tolum
J& #39;ajoute un passage intéressant:
"Vaccinees infected at least a week after the second dose were disproportionally infected with B.1.351 (odds ratio of 8:1). Those infected between two weeks after the first dose and one week after the second dose, were disproportionally
"Vaccinees infected at least a week after the second dose were disproportionally infected with B.1.351 (odds ratio of 8:1). Those infected between two weeks after the first dose and one week after the second dose, were disproportionally
infected by B.1.1.7 (odds ratio of 26:10), suggesting reduced vaccine effectiveness against both VOCs under different dosage/timing conditions."
